These factors contribute to dermatologic health disparities and should be considered when planning patient care, as they can affect adherence to treatment and access to care.
Molecular testing in dermatology involves decisions about who gets tested, how to test and interpret results, and where to go for help in interpreting results.
Almost three quarters of survey respondents reported experiencing psychological and emotional stress or burnout associated with being a Mohs surgeon and 68% reported a musculoskeletal injury.
Certain minority populations may be at a higher risk of being prescribed opioids post-operatively, which may confer further risks of complications of chronic opioid use.
Despite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy.
Researchers have identified biomarkers, alongside clinical risk factors, that may provide better cancer risk assessment and identify individuals who should be screened.
Linking hospital patients to virtual nurses via a computer screen could reduce the administrative tasks of bedside nurses -- and provide a rewarding alternative career path for some overworked nurses.
Cutaneous immune-related adverse events are associated with a better prognosis among patients with cancer who receive immune checkpoint inhibitors, new research suggests.
A bill introduced in the Senate would allow Medicare to provide coverage for multi-cancer screening tests once they have been approved and proven to show clinical benefit.
As more states legalize the use of medical marijuana, advocates say there’s need for nurses and nursing students to provide accurate patient education, but curriculum and licensing is lacking.
Although still controversial, transplantation is gaining traction as a treatment option for patients with colorectal liver metastases and intrahepatic cholangiocarcinoma.
Antibody-drug conjugates are a promising new option for gynecologic cancers, but they have a variety of ocular or vision-related adverse events that need to be appropriately monitored and managed.
